Autologous Bronchial Basal Cells Transplantation for Treatment of Bronchiectasis
Clinical trial NCT02722642 · UNKNOWN
Trial details
- NCT number
- NCT02722642
- Sponsor
- Regend Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2020-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.